XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.

- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.

The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Which Crypto ETF Drew the Most Money Last Week?
Weekly crypto ETF flow data for the period ending September 19, 2026 points to a product outside the two largest spot funds attracting the most net new capital,...
Bitcoin Above $80,000 as $180M Crypto Shorts Liquidated
Bitcoin broke above $80,000 on September 18, 2026, touching an intraday high of $80,857 and triggering a cascade of forced short closures across crypto derivati...
Bitcoin Reclaims $80K as SEC, CFTC Advance After CLARITY Failure
Bitcoin reclaimed the $80,000 level on September 19, 2026, trading at $81,012 as the SEC and CFTC continued advancing their joint crypto oversight agenda follow...
TRM Labs Flags 9 Fake Claude Crypto Arbitrage Bot Tutorials
According to TRM Labs, the campaign consists of nine videos on YouTube, each framed as a step-by-step guide to building automated crypto arbitrage tools with th...
Binance Cuts Collateral Ratios for Six Tokens; Coinbase International Removes 29 Assets
Two of the largest crypto exchanges announced risk-management changes on the same day: Binance is cutting collateral ratios for six tokens, reducing how much bo...
Report Says ECB President Urged Blocking Binance EU License
A report claims ECB President Christine Lagarde personally urged European officials to block Binance from obtaining an EU-wide crypto license, a development tha...